Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021–2022 - Top-Institutions - MDSpire

Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021–2022

  • By

  • Stephanie Goya

  • Seffir T Wendm

  • Hong Xie

  • Tien V Nguyen

  • Sarina Barnes

  • Rohit R Shankar

  • Jaydee Sereewit

  • Kurtis Cruz

  • Ailyn C Pérez-Osorio

  • Margaret G Mills

  • Alexander L Greninger

  • July 4, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Viral Genomics
    • Infectious Disease Epidemiology
    • Bioinformatics

  • #2

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Viral Epidemiology
    • Public Health Surveillance
    • Genomic Epidemiology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Viral Genomics
    • Clinical Virology

  • #4

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomics
    • Computational Biology
    • Infectious Disease Research

Original Source(s)

Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021–2022

  • by Stephanie Goya, Seffir T Wendm, Hong Xie, Tien V Nguyen, Sarina Barnes, Rohit R Shankar, Jaydee Sereewit, Kurtis Cruz, Ailyn C Pérez-Osorio, Margaret G Mills, Alexander L Greninger

  • July 4, 2024

Related Content

What to know about hantavirus, the illness suspected in a cruise ship outbreak

Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract Infections

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.